Catalent Joins Business Ethics Leadership Alliance

Catalent Joins Business Ethics Leadership Alliance

Date: 06/16/2010

Somerset, NJ, June 16, 2010 — Catalent Pharma Solutions, Inc. has joined the Business Ethics Leadership Alliance (BELA), a groundbreaking initiative founded by The Ethisphere Institute that promotes ethical business practices. Catalent has aligned itself with other BELA members, some of the most well known and respected brands in the world, to promote core business ethics values.

“Becoming part of BELA formalizes our historical commitment to business ethics,” said Diane Duvall, Vice President Associate General Counsel, Ethics and Compliance. “BELA offers a unique opportunity to join with other like-minded companies that also recognize the connection between ethical business behavior and strong operating performance and brand. We are excited by the potential to improve the overall corporate environment and its public perception while learning and sharing best practices with the other members.”

BELA seeks to establish a benchmark framework for ethical behavior in the corporate world by focusing on four core values: legal compliance, transparency, conflict identification and accountability.

“We are thrilled that Catalent has joined BELA as a strong advocate of these core principles,” said Alex Brigham, Executive Director of The Ethisphere Institute and founder of BELA. “We congratulate Catalent on the decision to take action by demonstrating a commitment to supporting responsible business practices and look forward to its contributions to BELA’s collaborative efforts to create a more ethical business environment for all.”

About Catalent

Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 people at 30 facilities worldwide and in fiscal 2009 generated more than $1.6 billion in annual revenue. For more information, visit .

more products. better treatments. reliably supplied.™